Goldman Sachs’s Ocugen OCGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $3.42M | Buy |
3,316,453
+2,295,559
| +225% | +$2.92M | ﹤0.01% | 4242 |
|
|
2026
Q2 | $1.56M | Sell |
1,020,894
-106,512
| -9% | -$162K | ﹤0.01% | 4869 |
|
|
2026
Q1 | $2.04M | Sell |
1,127,406
-1,175,069
| -51% | -$2.03M | ﹤0.01% | 4535 |
|
|
2025
Q4 | $3.11M | Buy |
2,302,475
+2,204,765
| +2,256% | +$3.14M | ﹤0.01% | 4199 |
|
|
2025
Q3 | $159K | Sell |
97,710
-789,342
| -89% | -$875K | ﹤0.01% | 5996 |
|
|
2025
Q2 | $861K | Buy |
887,052
+286,373
| +48% | +$238K | ﹤0.01% | 4808 |
|
|
2025
Q1 | $424K | Sell |
600,679
-225,168
| -27% | -$156K | ﹤0.01% | 5281 |
|
|
2024
Q4 | $665K | Sell |
825,847
-106,890
| -11% | -$97.9K | ﹤0.01% | 5075 |
|
|
2024
Q3 | $925K | Buy |
932,737
+173,297
| +23% | +$238K | ﹤0.01% | 4686 |
|
|
2024
Q2 | $1.18M | Sell |
759,440
-1,848,185
| -71% | -$2.88M | ﹤0.01% | 4331 |
|
|
2024
Q1 | $4.28M | Buy |
+2,607,625
| New | +$2.19M | ﹤0.01% | 3237 |
|
|
2023
Q3 | – | Sell |
-70,669
| Closed | -$38.4K | – | 5763 |
|
|
2023
Q2 | $38.4K | Sell |
70,669
-634,231
| -90% | -$407K | ﹤0.01% | 5488 |
|
|
2023
Q1 | $601K | Sell |
704,900
-840,315
| -54% | -$916K | ﹤0.01% | 4728 |
|
|
2022
Q4 | $2.01M | Sell |
1,545,215
-448,705
| -23% | -$699K | ﹤0.01% | 3944 |
|
|
2022
Q3 | $3.55M | Buy |
1,993,920
+416,256
| +26% | +$1.04M | ﹤0.01% | 3454 |
|
|
2022
Q2 | $3.58M | Buy |
1,577,664
+596,736
| +61% | +$1.43M | ﹤0.01% | 3504 |
|
|
2022
Q1 | $3.24M | Buy |
980,928
+760,306
| +345% | +$2.67M | ﹤0.01% | 3775 |
|
|
2021
Q4 | $1M | Sell |
220,622
-4,777
| -2% | -$36.1K | ﹤0.01% | 4834 |
|
|
2021
Q3 | $1.62M | Sell |
225,399
-7,151
| -3% | -$52.5K | ﹤0.01% | 4373 |
|
|
2021
Q2 | $1.87M | Sell |
232,550
-94,018
| -29% | -$793K | ﹤0.01% | 4268 |
|
|
2021
Q1 | $2.22M | Buy |
326,568
+315,310
| +2,801% | +$2.1M | ﹤0.01% | 3887 |
|
|
2020
Q4 | $21K | Buy |
+11,258
| New | +$5.42K | ﹤0.01% | 5435 |
|
|
2017
Q3 | – | Sell |
-196
| Closed | -$21K | – | 6789 |
|
|
2017
Q2 | $21K | Buy |
+196
| New | +$20.1K | ﹤0.01% | 6547 |
|
|
2015
Q4 | – | Sell |
-193
| Closed | -$46K | – | 7283 |
|
|
2015
Q3 | $46K | Sell |
193
-153
| -44% | -$55.3K | ﹤0.01% | 6821 |
|
|
2015
Q2 | $134K | Sell |
346
-357
| -51% | -$172K | ﹤0.01% | 6443 |
|
|
2015
Q1 | $422K | Buy |
703
+211
| +43% | +$122K | ﹤0.01% | 5310 |
|
|
2014
Q4 | $325K | Buy |
+492
| New | +$325K | ﹤0.01% | 5705 |
|
Other funds holding OCGN
Goldman Sachs's OCGN Position: Q3 2026 in Review
Goldman Sachs increased its Ocugen (OCGN) stake by 225% in Q3 2026, buying an estimated $2.92M and bringing the position to 3,316,453 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #4242.
Goldman Sachs first reported a position in OCGN in Q4 2014 and has held it in 27 quarters since. The position peaked at $4.28M in Q1 2024. 147 funds tracked by Wall St. Rank hold OCGN as of Q3 2026.
- Goldman Sachs held 3,316,453 shares of Ocugen worth $3.42M as of Q3 2026.
- Goldman Sachs bought 2,295,559 Ocugen shares in Q3 2026, an estimated $2.92M.
- Ocugen made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #4242 holding.
- Goldman Sachs first reported a position in Ocugen in Q4 2014 and has held it in 27 quarters since.
- Goldman Sachs's Ocugen position peaked at $4.28M in Q1 2024.
- 147 funds tracked by Wall St. Rank held Ocugen as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.